New collaboration will develop assays that offer a streamlined workflow for analysing even the most challenging genes. MINNEAPOLIS, Dec. 1, 2022 /PRNewswire/ -- Asuragen, a Bio-Techne brand (NASDAQ: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results